Addison Capital Co Has $1.906 Million Stake in Monsanto Company (MON)
Addison Capital Co decreased its position in Monsanto Company (NYSE:MON) by 1.4% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 16,841 shares of the basic materials company’s stock after selling 235 shares during the period. Monsanto Company comprises approximately 1.5% of Addison Capital Co’s holdings, making the stock its 25th largest position. Addison Capital Co’s holdings in Monsanto Company were worth $1,906,000 as of its most recent filing with the SEC.
Several other institutional investors also recently made changes to their positions in MON. Town & Country Bank & Trust CO dba First Bankers Trust CO increased its position in shares of Monsanto Company by 10.7% in the first quarter. Town & Country Bank & Trust CO dba First Bankers Trust CO now owns 6,956 shares of the basic materials company’s stock worth $787,000 after buying an additional 675 shares in the last quarter. Prospera Financial Services Inc increased its position in shares of Monsanto Company by 90.8% in the first quarter. Prospera Financial Services Inc now owns 3,754 shares of the basic materials company’s stock worth $430,000 after buying an additional 1,786 shares in the last quarter. Grassi Investment Management increased its position in shares of Monsanto Company by 0.9% in the first quarter. Grassi Investment Management now owns 47,275 shares of the basic materials company’s stock worth $5,352,000 after buying an additional 400 shares in the last quarter. First PREMIER Bank increased its position in shares of Monsanto Company by 4.2% in the first quarter. First PREMIER Bank now owns 901 shares of the basic materials company’s stock worth $102,000 after buying an additional 36 shares in the last quarter. Finally, Bank of Montreal Can increased its position in shares of Monsanto Company by 17.2% in the first quarter. Bank of Montreal Can now owns 664,718 shares of the basic materials company’s stock worth $75,246,000 after buying an additional 97,355 shares in the last quarter. 75.18% of the stock is owned by institutional investors and hedge funds.
Shares of Monsanto Company (NYSE:MON) traded down 0.20% during midday trading on Tuesday, reaching $115.96. The company’s stock had a trading volume of 332,538 shares. The company’s 50-day moving average price is $114.37 and its 200 day moving average price is $107.20. The firm has a market capitalization of $50.88 billion, a PE ratio of 26.68 and a beta of 0.93. Monsanto Company has a 1-year low of $88.76 and a 1-year high of $116.60.
Monsanto Company (NYSE:MON) last released its quarterly earnings data on Wednesday, April 5th. The basic materials company reported $3.19 EPS for the quarter, topping analysts’ consensus estimates of $2.79 by $0.40. The company had revenue of $5.07 billion for the quarter, compared to the consensus estimate of $4.73 billion. Monsanto Company had a return on equity of 47.05% and a net margin of 11.61%. The company’s quarterly revenue was up 12.0% compared to the same quarter last year. During the same period last year, the business posted $2.42 EPS. On average, equities research analysts forecast that Monsanto Company will post $4.90 earnings per share for the current year.
The business also recently announced a quarterly dividend, which will be paid on Friday, April 28th. Stockholders of record on Friday, April 7th will be paid a $0.54 dividend. The ex-dividend date is Wednesday, April 5th. This represents a $2.16 dividend on an annualized basis and a dividend yield of 1.86%. Monsanto Company’s dividend payout ratio (DPR) is currently 58.86%.
ILLEGAL ACTIVITY WARNING: This news story was originally published by Daily Political and is owned by of Daily Political. If you are accessing this news story on another website, it was copied illegally and republished in violation of US and international copyright and trademark legislation. The correct version of this news story can be viewed at http://www.dailypolitical.com/2017/04/18/addison-capital-co-has-1-906-million-stake-in-monsanto-company-mon.html.
A number of equities analysts have recently commented on the company. Citigroup Inc reissued a “neutral” rating and set a $125.00 price objective (up from $122.00) on shares of Monsanto Company in a research report on Friday. Royal Bank of Canada reissued a “hold” rating and set a $120.00 price objective on shares of Monsanto Company in a research report on Friday, April 7th. BMO Capital Markets reissued a “buy” rating and set a $128.00 price objective on shares of Monsanto Company in a research report on Wednesday, April 5th. Vetr raised Monsanto Company from a “hold” rating to a “buy” rating and set a $118.00 price objective for the company in a research report on Monday, April 3rd. Finally, Jefferies Group LLC reissued a “buy” rating and set a $128.00 price objective on shares of Monsanto Company in a research report on Tuesday, March 28th. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating and fourteen have assigned a buy rating to the stock. The company presently has an average rating of “Buy” and a consensus price target of $118.94.
In other news, EVP Steven Mizell sold 13,700 shares of the stock in a transaction dated Monday, April 10th. The stock was sold at an average price of $116.11, for a total value of $1,590,707.00. Following the completion of the sale, the executive vice president now owns 50,295 shares in the company, valued at $5,839,752.45. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Michael K. Stern sold 5,670 shares of the stock in a transaction dated Wednesday, January 25th. The shares were sold at an average price of $110.00, for a total value of $623,700.00. Following the completion of the sale, the chief executive officer now owns 20,534 shares of the company’s stock, valued at approximately $2,258,740. The disclosure for this sale can be found here. In the last quarter, insiders sold 168,600 shares of company stock valued at $19,547,472. Insiders own 0.79% of the company’s stock.
About Monsanto Company
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Company (NYSE:MON).
Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.